Trial Registration NCT05584670 References Lu D, Polonskaya Z, Pei-Chang C, A novel human anti-PD1/IL15 bi-functional protein with robust anti-tumor activity and low systemic toxicity. J Immunother Cancer. 2020;8(Suppl 3):A1-A559 Polonskaya Z, Pei-Chang C, Martimo S, MOA study of ...
These results support further evaluation of SAR445877 in a phase I clinical trial (ClinicalTrials.gov #NCT05584670).Marie BernardoYu-an ZhangDan LuStella MartomoFatima MenasChen ZhuRaymond PerezJeegar PatelDonald ShafferXiangming LiCancer research...